A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition ...

The study included 29 eyes of 28 patients receiving intravitreal 2 mg/0.05 ml aflibercept injection for the treatment of wet AMD resistant to intravitreal ranibizumab injections. There were 11 females ...

Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a ...

A panel of ophthalmologists defined points of consensus for suprachoroidal space injections based on current published evidence. IVT is the primary method of delivering therapeutics in the eye, ...

Please provide your email address to receive an email when new articles are posted on . Age-related macular degeneration is one of the leading causes of vision loss in the elderly population. Although ...

This prospective randomized clinical trial was approved by the Miami Veterans Affairs Medical Center Institutional Review Board and was HIPAA compliant. The study was registered with ClinicaTrials.gov ...

Ocular Therapeutix has provided promising updates on its clinical trials for Axpaxli and Paxtrava, utilizing its Elutyx drug-eluting platform. The company has appointed a new CEO and raised funds, ...

A newly published clinical trial appeared in Nature Medicine on April 1. The trial was conducted on patients suffering from Leber congenital amaurosis, a rare and genetic eye disorder. One trial ...